Clinical Trials Browser

Phase 3 × Active not recruiting × Nonsquamous Non-small Cell Lung Cancer × Clear all

NCT05338970 2025-01-31

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Phase 3 Active not recruiting

Nonsquamous Non-small Cell Lung Cancer